$3.95
arrow_drop_down3.65%Key Stats | |
---|---|
Open | $3.88 |
Prev. Close | $3.85 |
EPS | -31.25 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $3.83M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 3.80 | 4.20 |
52 Week Range | 2.75 | 17.00 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -31.25 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Theriva Biologics anuncia el desdoblamiento inverso de sus acciones
Theriva™ Biologics anuncia la designación de vía rápida concedida por la FDA estadounidense al VCN-01 para el tratamiento del cáncer de páncreas metastásico
Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
Theriva™ Biologics participará en la conferencia virtual de salud de A.G.P.
Theriva™ Biologics to Participate in the A.G.P. Virtual Healthcare Conference
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del primer trimestre de 2024